Zika, Denge, Yellow Fever & Syphilis Cause & Care

American Medical Detective Div., General T. Red, LLC

George A. Farber, Sr,. MD

George A. Farber, Sr., MD. Col. U.S.A. (R), U.S.A.F.(M.C.). (Ret.) 5 Chateau Petrus Dr. Kenner, LA 70065-2058 Ph: 504/583-4593

http://www.americanmedicaldetective.com/

Zika, Dengue,

Yellow Fever & Syphilis

Cause & Care

Zika, Denge, Yellow Fever & Syphilis Cause & Care



Zika is a long known viral infectious disease indigenous in

man-like, creatures, namely monkeys, abiding in Africa.

Monkeys do not travel, man does.

Man (humans) that become infected carry the disease far and

wide, thereby creating new areas of indigence,

and can create epidemics wherever mosquitos exist, to

become vectors.




Monkeys in indigenous areas have adapted and developed

levels of immunity for survival, but become carriers, which

results in prolonging the disease entity.

As with all creature and forms of life, the proposition of “survival

of the fittest” prevails.




Humans will adapt, develop immunity and mostly survive,

although there will be the aspects of fetal defects, that may

occur in pregnant females that become infected.

Mosquitos wherever they exist, are the main vectors or

transfer agents. Mosquitos suck blood with non-specific

selectivity and thereby transfer the disease to other creatures

and humankind as well.




These vectors historically have started other

epidemics of huge proportions and

consequences, such as

Yellow Fever, Malaria, and Dengue Fever.




Once infected, humans become carriers. The virus colonizes in

blood, lymphatic, brain, cerebrospinal fluid, and various organs,

such as salivary glands, prostate, seminal glands and other

depot organs and structures.

Humans can become a vector or transmitter agent when they

become carriers. They can spread the disease by transfusions,

sexual exposures, via mosquitos or by incidental exposure

such as via reused syringes and needles, condoms, and other

vehicles.




Zika is similar to Dengue Fever Virus, as

noted macroscopically. The visual

appearance compares to other known

diseases, similar in appearance but

different in antigenicity, and other aspects.




There are Public Heath similarities as to both Zika and Syphilis

epidemics and pandemics. Syphilis was endemic in South

American mammals (Llamas) and spread to humans by sexual

exposure and possibly by other vectors.

The native humans lived with the disease for centuries. When

the European explorers and conquistadors arrived, they quickly

contracted the disease, and those that survived and returned to

Europe, promptly created a pandemic of huge consequences.




The death rate in Europe was huge. However, more likely than

not, the death rate was related to the palliative medications

prescribed, consisting of heavy metals such as Mercurials.

There has never been a spirochetocidal cure. There is no

evidence of immunity to Syphilis. There are reasonable

medication treatments for control of progression of this

disease.




However, the human body has other natural

defenses, such as localization by granuloma

formation which essentially corals the spirochetes

in tissues, including the brain.

Antibody development may occur, but is not

curative.




So, what is the cure for Zika?

That remains to be seen. There are many ways to control this

disease well ensconced in Public Health measures and with

International Agencies working together with regional and local

organizations. However, there is a need for immediate

treatment, to be followed by mass protective measures, such

as a vaccine to be manufactured and made available. Such

vaccine treatment is expensive in time and financial aspects

and cooperative efforts.




In the meantime, there are safe, good, valuable, effective and

available treatments for immediate impact.

They worked exceedingly well in Vietnam in 1966-1967, once

the diagnosis of Dengue Fever was ascertained and epidemic

aspects determined by sheer numbers, by a Flight Surgeon-

Dermatologist-Syphillologist and an Internal Medical Infectious

Disease Physician, Chief of Internal Medicine at Cam Ranh

Bay U.S.A.F Hospital, Vietnam.




There being no specific anti-viral treatment at

that time or place, supportive treatments and

measures were in good order. The approach

was simplified.

This consisted of immediate notice and

supportive education to responsible Military

Chain of Command, medical personal locally

and via chain of command to all medical

personal in the S.E Asia theater.




Logistic support included adequate supplies of medication,

sufficient for the projected case load in the combat and

adjacent areas, plus the entire theater, and military and civilian

and merchant marine contract ”assets”.

The Public Health measures required inclusion of theater

personal as well as all personal rotating back to USA or other

assignments, both mosquito endemic and non-mosquito

habitats.




The available medication for immediate treatment consisted of

a broad Spectrum, reliable, safe Macrolide antibiotic that was

relatively new. That injectable product was Lincomycin-HCL*,

300 mg/cc, provided in multi-dose vials that did not require

refrigeration.

The second medication, also reliably safe for IM injection, was

repository injectable Methyl-Prednisolone, (Depo-Medrol)* (40

mg/cc) in multi-dose vials, refrigeration not required. This

medication remains today as an excellent repository anti-

inflammatory medication.




The initial and continued rationale was to “Clean House” of any

minor or occult infection; prophylactically prevent any

opportunistic new infection from interfering with the presumed

immunity system to develop antibodies for the Dengue Fever

Virus, (Divide & Conquer Philosophy); allowing the immune

system to concentrate on the Dengue Fever.




The target was any minor or occult infection such as sinusitis

(nasopharyngeal), dental focal abscesses, common-place

acneiform infections of face, scalp, and full body, minor genito–

urinary infection, follicular micro- abscess infection, micro joint

infection, etc.

This empiric treatment was by single IM dose injection of

Lincomycin HCL, 450 mg (1.5 cc).




The second medication (Methyl-Prednisolone) was to treat the

inflammatory aspect of the disease process, both internally and

cutaneously.

The manifestations included edema, erythema multiforme

rashes, pruritus, cephalalgia, arthralgia, vertigo,

nasopharyngeal signs and symptoms, malaise and fever, and

internal tissue inflammation, presumed but not specifically

identified.




Note: Laboratory testing typically not available in combat areas.

The above approach worked, and worked well and

immediately. There were no reported nor identified adverse

reactions or delayed side effects of any kind. The average

patient was declared “fit for duty “after one week. An occasional

patient required a second dose of each medication after one

week. None required further treatments. Thousands of troops

were involved.




Lessons learned;

Rapid diagnosis, rapid treatment, rapid Public Heath reaction

and logistical support resulting in rapid care and containment.

Because of the similarity of Zika and Dengue Fever, there may

be sufficient rationale to initiate the same immediate treatment

as was successful in Vietnam, for Zika infections




Note (A).

This author was that Flight Surgeon Dermatologist and

Syphillologist in Vietnam. The internist (Lt/Col. at that time) was

promoted to full Colonel and later retired and became a Chief

of Staff at M.D. Anderson Hospital in Houston, Texas, Frederick

“Bud” Conrad, MD (Deceased).

Note (B).

Lincomycin* & Depo-Medrol*; Pfizer Pharmaceutical. Co.

Zika, Denge, Yellow Fever & Syphilis Cause & Care

Health & Medicine

Transcript of Zika, Denge, Yellow Fever & Syphilis Cause & Care